Application of Failure Mode and Effects Analysis in risk management of drug therapy in an intensive care unit
DOI:
https://doi.org/10.30827/ars.v65i3.29973Keywords:
Risk Assessment, Patient Safety, Quality of Health Care, Critical CareAbstract
Objective: To utilize Failure Mode and Effects Analysis (FMEA) to manage risks in prescribed drug therapy within an Intensive Care Unit (ICU).
Methodology: This action research, integrating qualitative and quantitative methods, assesses medical prescriptions in a Coronary ICU (CECOR) in Fortaleza, Brazil, using FMEA. This study involves defining the process, forming a multidisciplinary team, conducting a situational diagnosis, evaluating failure modes (FMs) with Severity (S) and Detection (D) indices, monitoring FM Prevalence (P), and calculating the Prioritization Coefficient (PC). Each FM is accompanied by pharmaceutical recommendations (RF). Continuing education activities are designed based on the PC for CECOR professionals.
Results: In the situational diagnosis, 170 prescriptions and 60 FMs were assessed, with primary categories being drug interactions (39.7 %) and incompatibilities (30.0 %). Causes are multifactorial. Regarding the team’s response to an FM, it was determined that 36,7 % of the FMs would be accepted with monitoring. During prevalence monitoring, 63.3 % of FM types occurred 837 times, with high severity (50.0 %) and low detection (55.3 %). Most frequent FMs were absence of pharmaceutical form (29.4 %) and dose (8.8 %).
Conclusion: FMEA facilitates identifying, classifying, and prioritizing risks in drug therapy at CECOR, underlining its effectiveness as a quality tool for enhancing patient safety.
Downloads
References
Marshall JC, Bosco L, Adhikari NK, et al. What is an intensive care unit? A report of the task force of the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care. 2017;37:270-6. doi: 10.1016/j.jcrc.2016.07.015. DOI: https://doi.org/10.1016/j.jcrc.2016.07.015
Camiré E, Moyen E, Stelfox HT. Medication errors in critical care: risk factors, prevention and disclosure. CMAJ. 2009;180(9):936-43. doi: 10.1503/cmaj.080869. DOI: https://doi.org/10.1503/cmaj.080869
Kane-Gill SL, Jacobi J, Rothschild JM. Adverse drug events in intensive care units: risk factors, impact, and the role of team care. Crit Care Med. 2010;38(6 Suppl):S83-9. doi: 10.1097/CCM.0b013e3181dd8364. DOI: https://doi.org/10.1097/CCM.0b013e3181dd8364
Institute of Medicine (US) Committee on Quality of Health Care in America. To Err is Human: Building a Safer Health System. Kohn LT, Corrigan JM, Donaldson MS, editors. Washington (DC): National Academies Press (US); 2000. PMID: 25077248.
Agency For Healthcare Research And Quality(AHRQ). Saving lives and saving money: hospital-acquired conditions update. Interim Data From National Efforts To Make Care Safer, 2010-2014. Content last updated December 2015. Agency for Healthcare Research and Quality, Rockville, MD. Available in: <https://www.ahrq.gov/hai/pfp/interimhacrate2014.html> Access: 1/5/2016.
Aspden P, Wolcott J, Bootman JL, et al, eds; Institute of Medicine, Committee on Identifying and Preventing Medication Errors. Washington DC: National Academies Press; 2007. ISBN 0309101476.
Machado APC, Tomich CSF, Osme SF, et al. Prescribing errors in a Brazilian neonatal intensive care unit. Cad. Saúde Pública. 2015;31(12):2610-20. DOI: https://doi.org/10.1590/0102-311X00194714
World Health Organization. Conceptual framework for the international classification for patient safety. Version 1.1. Final Technical Report. c2011 [cited 2018 jan 26]. Available in: https://proqualis.net/sites/proqualis.net/files/Estrutura%20Conceitual%20da%20Classifica%C3%A7%C3%A3o%20Int%20Seguran%C3%A7a%20do%20Paciente.pdf
Manual de políticas e estratégias para a qualidade dos cuidados de saúde: uma abordagem prática para formular políticas e estratégias destinadas a melhorar a qualidade dos cuidados de saúde [Handbook for national quality policy and strategy: a practical approach for developing policy and strategy to improve quality of care]. Genebra: Organização Mundial da Saúde; 2020.
Galdino SV, Reis EMB, Santos CB, et al. Ferramentas de qualidade na gestão dos serviços de saúde: revisão integrativa de literatura. Revista Eletrônica Gestão & Saúde. 2016;7(1):1023–57. DOI: https://doi.org/10.18673/gs.v0isupl..22005
Liu HC, Zhang LJ, Ping YJ, et al. Failure mode and effects analysis for proactive healthcare risk evaluation: A systematic literature review. J Eval Clin Pract. 2020 Aug;26(4):1320-1337. doi: 10.1111/jep.13317. DOI: https://doi.org/10.1111/jep.13317
Vida MAC, Plata JEM, Morales-Molina JÁ, et al. Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysis. Eur J Hosp Pharm. 2019;26(2):66-72. doi: 10.1136/ejhpharm-2017-001242. DOI: https://doi.org/10.1136/ejhpharm-2017-001242
Duwe B, Fuchs BD, Hansen-Flaschen J. Failure mode and effects analysis application to critical care medicine. Crit Care Clin. 2005;21(1):21-30, vii. doi: 10.1016/j.ccc.2004.07.005. DOI: https://doi.org/10.1016/j.ccc.2004.07.005
Sidney KM, Chaves EF, Costa HM, et al. Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit. Rev Bras Farm Hosp Serv Saude. 2021;12(3):0606. doi: 10.30968/rbfhss.2021.123.0606. DOI: https://doi.org/10.30968/rbfhss.2021.123.0606
Hussain E, Kao E. Medication safety and transfusion errors in the ICU and beyond. Crit Care Clin. 2005 Jan;21(1):91-110, ix. doi: 10.1016/j.ccc.2004.08.003. DOI: https://doi.org/10.1016/j.ccc.2004.08.003
Ashley L, Armitage G, Neary M, et al. A practical guide to failure mode and effects analysis in health care: making the most of the team and its meetings. Jt Comm J Qual Patient Saf. 2010;36(8):351-8. doi: 10.1016/s1553-7250(10)36053-3. DOI: https://doi.org/10.1016/S1553-7250(10)36053-3
Micromedex® Healthcare Series. 2015. Avaliable in: <http://www-DRUGDEXsolutionscom.ez11.periodicos.capes.gov.br/DRUGDEX2/librarian/.> Access: 15 November 2017.
UpToDate®. 2019. Available in:<https://www.uptodate.com/contents/search> Access: 14 Jun 2019.
Seeber I, Vreede GJ, Maier R, et al. Beyond Brainstorming: Exploring Convergence in Teams. J Manag Inf Syst. 2017;34(4):939–69. doi: 10.1080/07421222.2017.1393303. DOI: https://doi.org/10.1080/07421222.2017.1393303
Picarillo AP. Introduction to quality improvement tools for the clinician. J Perinatol. 2018 Jul;38(7):929-935. doi: 10.1038/s41372-018-0100-4. Epub 2018 May 24. PMID: 29795322. DOI: https://doi.org/10.1038/s41372-018-0100-4
Farré R, Clopés A, Sala ML, et al. Intervenciones farmacéuticas (parte I): metodología y evaluación. Farm Hosp 2000; 24(3):136-44.
Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos Potencialmente Perigosos de Uso Hospitalar e Ambulatorial - Listas Atualizadas 2015. Boletim ISMP Brasil. 2015; 4(3). Available in: <http://www.ismp-brasil.org/site/wp-content/uploads/2015/12/V4N3.pdf>. Access: 12 Jun 2022.
Bosma BE, Hunfeld NGM, Roobol-Meuwese E, et al. Voluntarily reported prescribing, monitoring, and medication transfer errors in intensive care units in The Netherlands. Int J Clin Pharm. 2021;43(1):66-76. doi: 10.1007/s11096-020-01101-5. DOI: https://doi.org/10.1007/s11096-020-01101-5
Cho I, Park H, Choi YJ, et al. Understanding the Nature of Medication Errors in an ICU with a Computerized Physician Order Entry System. PLoS ONE. 2014;9(12):e114243. doi:10.1371/journal.pone.0114243
Gracia JE, Sanz AA, Serrano RB, et al. Medication errors and risk areas in a critical care unit. J Adv Nurs. 2021;77(1):286-95. doi: 10.1111/jan.14612. DOI: https://doi.org/10.1111/jan.14612
Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf. 2005;28(3):251-61. doi: 10.2165/00002018-200528030-00006. DOI: https://doi.org/10.2165/00002018-200528030-00006
Anjalee JAL, Rutter V, Samaranayake NR. Application of failure mode and effects analysis (FMEA) to improve medication safety in the dispensing process - a study at a teaching hospital, Sri Lanka. BMC Public Health. 2021 Jul 20;21(1):1430. doi: 10.1186/s12889-021-11369-5. DOI: https://doi.org/10.1186/s12889-021-11369-5
Malfará M, Pernassi M, Aragon D, Carlotti A. Impact of the clinical pharmacist interventions on the prevention of pharmacotherapy related problems in the pediatric intensive care unit. Int J Clin Pharm. 2018 Jun;40(3):513-9. doi: 10.1007/s11096-018-0632-x.
Rodriguez-Gonzalez CG, Martin-Barbero ML, Herranz-Alonso A, et al. Use of failure mode, effect, and criticality analysis to improve safety in the medication administration process. J Eval Clin Pract. 2015;21(4):549-59. doi: 10.1111/jep.12314. DOI: https://doi.org/10.1111/jep.12314
Stollings JL, Bloom SL, Wang L, et al. Critical Care Pharmacists and Medication Management in an ICU Recovery Center. Ann Pharmacother. 2018 Aug;52(8):713-723. doi: 10.1177/1060028018759343. DOI: https://doi.org/10.1177/1060028018759343
Adriano LS. Farmácia clínica em unidade de terapia intensiva: identificação, resolução e prevenção de erros de medicação. 2016. 76 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Faculdade de Farmácia, Odontologia e Enfermagem, Universidade Federal do Ceará, Fortaleza, 2016.
Ferrández O, Casañ B, Graua S, et al. Análisis de los problemas relacionados con los medicamentos en un hospital de tercer nivel de Barcelona. Gaceta Sanitaria. 2018;33(4):361-8. doi: 10.1016/j.gaceta.2018.01.002. DOI: https://doi.org/10.1016/j.gaceta.2018.01.002
Askari M, Eslami S, Louws M, et al. Frequency and nature of drug-drug interactions in the intensive care unit. Pharmacoepidemiol Drug Saf. 2013;22(4):430-7. doi: 10.1002/pds.3415. DOI: https://doi.org/10.1002/pds.3415
Valentin A. Approaches to decreasing medication and other care errors in the ICU. Curr Opin Crit Care. 2013;19(5):474-9. doi: 10.1097/MCC.0b013e328364d4f9. DOI: https://doi.org/10.1097/MCC.0b013e328364d4f9
Lao GC, Reyes MR, Turet JR, et al. Compatibilidad de los fármacos administrados en «Y» en las unidades de cuidados intensivos: revisión sistemática. Medicina Intensiva. 2020;44(2):80-7. doi: 10.1016/j.medin.2018.08.004. DOI: https://doi.org/10.1016/j.medin.2018.08.004
Miarons M, Marín S, Amenós I, et al. Pharmaceutical interventions in the emergency department: cost-effectiveness and cost-benefit analysis. Eur J Hosp Pharm. 2021;28(3):133-8. doi: 10.1136/ejhpharm-2019-002067. DOI: https://doi.org/10.1136/ejhpharm-2019-002067
Calligaris L, Panzera A, Arnoldo L, et al. Errors and omissions in hospital prescriptions: a survey of prescription writing in a hospital. BMC Clin Pharmacol. 2009;9:9. doi: 10.1186/1472-6904-9-9. DOI: https://doi.org/10.1186/1472-6904-9-9
Cho I, Park H, Choi YJ, et al. Understanding the nature of medication errors in an ICU with a computerized physician order entry system. PLoS One. 2014;9(12):e114243. doi: 10.1371/journal.pone.0114243. DOI: https://doi.org/10.1371/journal.pone.0114243
Silveira ED, Díaz AA, Menéndez-Conde CP. Análisis modal de fallos y efectos del proceso de prescripción, validación y dispensación de medicamentos. Farm Hosp. 2012;36(1):24-32. doi: 10.1016/j.farma.2010.12.002. DOI: https://doi.org/10.1016/j.farma.2010.12.002
Duin TS, Carvalho MAF, Pype PF, et al. Junior doctors’ experiences with interprofessional collaboration: Wandering the landscape. Med Educ. 2022 Apr;56(4):418-31. doi: 10.1111/medu.14711. DOI: https://doi.org/10.1111/medu.14711
Lago P, Bizzarri G, Scalzotto F, et al. Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards: a quality improvement report. BMJ Open. 2012;2(6):e001249. doi: 10.1136/bmjopen-2012-001249. DOI: https://doi.org/10.1136/bmjopen-2012-001249
Fideles GM, Alcântara-Neto JM, Peixoto-Júnior AA, et al. Pharmacist recommendations in an intensive care unit: three-year clinical activities. Rev Bras Ter Intensiva. 2015;27(2):149-54. doi: 10.5935/0103-507X.20150026. DOI: https://doi.org/10.5935/0103-507X.20150026
Silva ACS, Sousa DSC, Perraud EBC et al. Acompanhamento farmacoterapêutico em unidade de terapia intensiva respiratória: descrição e análise de resultados. Einstein. 2018;16(2): eAO4112.
Malfará M, Pernassi M, Aragon D, et al. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int J Clin Pharm. 2018 Jun;40(3):513-519. doi: 10.1007/s11096-018-0632-x. DOI: https://doi.org/10.1007/s11096-018-0632-x
Shaughnessy AF, D’Amico F. Long-term experience with a program to improve prescription-writing skills. Fam Med. 1994;26:168–71.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Kamila Maria Maranhão Sidney, Elana Figueiredo Chaves, Jeanine Morais Pereira, Henrique Jorge Maia Costa, Marta Maria Fonteles de França
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
